Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy

November 16, 2011

AMSTERDAM, November 16, 2011 /PRNewswire/ –

SOURCE Amsterdam Molecular Therapeutics (AMT) B.V


Source: PR Newswire